Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2023-06-01
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531
Immunological Measurement of Aspartate/Alanine Aminotransferase
NCT03562585
Fibroscan to Guide Post Transplant Immunosuppression Minimization
NCT07206277
The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)
NCT05151913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Agreement metrics or SDC have not been addressed in previous studies for chronic viral hepatitis. The aim of this study is to assess agreement, SDC, and reliability of repeated measurements of liver stiffness of TE in patients with chronic viral hepatitis, and to explore factors associated with disagreement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic viral hepatitis
Transient elastography
Transient elastography measures liver stiffness in kPa
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transient elastography
Transient elastography measures liver stiffness in kPa
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients
* Signed informed consent to participate in the study.
Exclusion Criteria
* patients unable to speak Swedish
* inability to sign informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oskar Ljungquist, MD, PhD.
Role: PRINCIPAL_INVESTIGATOR
Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oskar Ljungquist
Helsingborg, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Oskar Ljungquist
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIV-22-08-040567
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.